Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
VentureMed Inc.
start up
United States
- Plymouth, Minnesota
- 30/10/2025
- Series C
- $28,000,000
VENTUREMED IS AN INNOVATOR in vessel preparation and drug delivery for the interventional treatment in AV access and PAD. The company’s Kinetic Micro-Incision Creation (K-MIC) make vessel preparation simpler, and more cost-effective with better outcomes. VentureMed offers interventionalists and their patients around the world state-of-the-art devices for treating lesions in AV and PAD. Founded by a vascular surgeon, VentureMed is committed to improving patient and economic outcomes.
- Industry Medical Device
- Website https://www.venturemedgroup.com/
- LinkedIn https://www.linkedin.com/company/venturemed-group/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)